$0.99
14.66% day before yesterday
Nasdaq, Apr 04, 10:00 pm CET
ISIN
US03837C1062
Symbol
APYX

Apyx Medical Corporation Target price 2025 - Analyst rating & recommendation

Apyx Medical Corporation Classifications & Recommendation:

Buy
33%
Hold
67%

Apyx Medical Corporation Price Target

Target Price $4.00
Price $0.99
Potential
Number of Estimates 1
1 Analyst has issued a Apyx Medical Corporation price target 2026. The average Apyx Medical Corporation target price is $4.00. This is higher than the current stock price.
A rating was issued by 3 analysts: 1 Analysts recommend Apyx Medical Corporation to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Apyx Medical Corporation stock has an average upside potential 2026 of . Most analysts recommend the Apyx Medical Corporation stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 48.10 48.04
8.12% 0.13%
EBITDA Margin -37.94% -12.66%
3.13% 66.63%
Net Margin -51.85% -32.11%
33.02% 38.08%

3 Analysts have issued a sales forecast Apyx Medical Corporation 2025 . The average Apyx Medical Corporation sales estimate is

$48.0m
Unlock
. This is
0.13% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$48.2m 0.18%
Unlock
, the lowest is
$47.9m 0.36%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $48.1m 8.12%
2025
$48.0m 0.13%
Unlock
2026
$51.5m 7.12%
Unlock

2 Analysts have issued an Apyx Medical Corporation EBITDA forecast 2025. The average Apyx Medical Corporation EBITDA estimate is

$-6.1m
Unlock
. This is
66.68% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-6.0m 67.33%
Unlock
, the lowest is
$-6.2m 66.03%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-18.3m 5.24%
2025
$-6.1m 66.68%
Unlock
2026
$-7.4m 21.68%
Unlock

EBITDA Margin

2024 -37.94% 3.13%
2025
-12.66% 66.63%
Unlock
2026
-14.38% 13.59%
Unlock

3 Apyx Medical Corporation Analysts have issued a net profit forecast 2025. The average Apyx Medical Corporation net profit estimate is

$-15.4m
Unlock
. This is
38.18% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-14.4m 42.43%
Unlock
, the lowest is
$-17.4m 30.32%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-24.9m 22.22%
2025
$-15.4m 38.18%
Unlock
2026
$-15.0m 2.46%
Unlock

Net Margin

2024 -51.85% 33.02%
2025
-32.11% 38.08%
Unlock
2026
-29.23% 8.97%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.66 -0.41
22.22% 37.88%
P/E negative
EV/Sales 0.93

3 Analysts have issued a Apyx Medical Corporation forecast for earnings per share. The average Apyx Medical Corporation EPS is

$-0.41
Unlock
. This is
37.88% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.38 42.42%
Unlock
, the lowest is
$-0.46 30.30%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.66 22.22%
2025
$-0.41 37.88%
Unlock
2026
$-0.40 2.44%
Unlock

P/E ratio

Current -1.49 40.87%
2025
-2.43 63.09%
Unlock
2026
-2.49 2.47%
Unlock

Based on analysts' sales estimates for 2025, the Apyx Medical Corporation stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.93 14.81%
2025
0.93 0.24%
Unlock
2026
0.87 6.65%
Unlock

P/S ratio

Current 0.78 13.57%
2025
0.78 0.13%
Unlock
2026
0.73 6.65%
Unlock

Current Apyx Medical Corporation Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BTIG
Locked
Locked
Locked Oct 17 2024
JMP Securities
Locked
Locked
Locked Sep 16 2024
Analyst Rating Date
Locked
BTIG:
Locked
Locked
Oct 17 2024
Locked
JMP Securities:
Locked
Locked
Sep 16 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today